Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Genoverde Biosciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Genoverde Biosciences

Genoverde Biosciences

US-based Genoverde Biosciences enhances energy crops with cell wall tech for efficient liquid fuel production.

HQ
Raleigh, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Genoverde Biosciences, founded in 2015 and headquartered in Raleigh, North Carolina, focuses on developing advanced cell wall technology to enhance lignocellulosic energy crops for efficient liquid fuel production. The company operates in the agri-bio tech sector, particularly within the hemp industry. Genoverde offers plant tissue culture for genetic resource storage, plant diagnostic testing for soil and plant health, and maintains a comprehensive cultivar library to support agricultural operations.

Genoverde Biosciences has made significant strides in improving the efficiency and profitability of energy crop production. Their innovative technologies have positioned them as leaders in the agri-bio tech field, particularly in the hemp industry. By providing essential services such as plant diagnostic testing and genetic resource storage, Genoverde supports sustainable agricultural practices and contributes to the advancement of biofuel production.

Genoverde Biosciences - Quick Facts

When was Genoverde Biosciences founded?

Genoverde Biosciences was founded in 2015.

Where is Genoverde Biosciences' headquarters located?

Genoverde Biosciences' headquarters is located in Raleigh, NC, US.

When was Genoverde Biosciences' last funding round?

Genoverde Biosciences' most recent funding round was for $954.5k (USD) in September 2018.

How much has Genoverde Biosciences raised to-date?

As of Sep 4, 2018, Genoverde Biosciences has raised a total of $1.2M (USD).

How many employees does Genoverde Biosciences have?

Genoverde Biosciences has 5 employees as of Feb 4, 2024.

Genoverde Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Biofuels
  • Energy Crops
Tags
  • AgTech
  • Cleantech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 9 more industry codes
NAICS
  • 220000Utilities
  • 221000Utilities
  • 620000Health Care and Social Assistance
SIC
  • 1300Oil And Gas Extraction
  • 1380Oil And Gas Field Services
  • 1382Oil And Gas Field Exploration Services
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified